US$ 20.35
weight watchers glp-1 program Goes All-In on GLP-1s With App Overhaul Weight Watchers Releases GLP-1 Results
Description
Are GLP-1s worth the investment for employers knowing that employees may leave before the long-term health and cost benefits are realized

Europ J Immunol

doi: 10.1080/17512433.2024.2421872

In comparison, without insurance coverage Wegovy, Novo Nordisks semaglutide product that has been approved for weight loss, has a list price of approximate $1,350 per month
Include supporting documentation from your provider, relevant clinical studies, and any evidence that alternative treatments have been tried and failed